Energy News Portal

Sustainable

Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool

Source: BioPharma Dive - Latest News

Some 1,390 Foundayo prescriptions were written in two days, according to analysts. Elsewhere, multiple biotechs are using OpenAI’s “GPT-Rosalind” and Janux debuted a “double-masked” T cell engager.

View Original Coverage